59 related articles for article (PubMed ID: 7752089)
1. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol.
Muñoz NM; Rabe KF; Vita AJ; McAllister K; Mayer D; Weiss M; Leff AR
J Pharmacol Exp Ther; 1995 May; 273(2):850-4. PubMed ID: 7752089
[TBL] [Abstract][Full Text] [Related]
2. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4.
Munoz NM; Vita AJ; Neeley SP; McAllister K; Spaethe SM; White SR; Leff AR
J Pharmacol Exp Ther; 1994 Jan; 268(1):139-43. PubMed ID: 8301549
[TBL] [Abstract][Full Text] [Related]
3. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils.
Leff AR; Herrnreiter A; Naclerio RM; Baroody FM; Handley DA; Muñoz NM
Pulm Pharmacol Ther; 1997; 10(2):97-104. PubMed ID: 9425641
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of salbutamol and salmeterol on human eosinophil responses.
Ezeamuzie CI; al-Hage M
J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin.
Neeley SP; Hamann KJ; Dowling TL; McAllister KT; White SR; Leff AR
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):206-13. PubMed ID: 8049081
[TBL] [Abstract][Full Text] [Related]
6. Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.
Meliton AY; Muñoz NM; Liu J; Lambertino AT; Boetticher E; Myo S; Myou S; Zhu X; Johnson M; Leff AR
J Allergy Clin Immunol; 2003 Aug; 112(2):404-10. PubMed ID: 12897749
[TBL] [Abstract][Full Text] [Related]
7. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
Ezeamuzie CI; al-Hage M; Nwankwoala RN
Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
[TBL] [Abstract][Full Text] [Related]
8. Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5.
Volcheck GW; Kelkar P; Bartemes KR; Gleich GJ; Kita H
Clin Exp Allergy; 2005 Oct; 35(10):1341-6. PubMed ID: 16238794
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
[TBL] [Abstract][Full Text] [Related]
10. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils.
Mio M; Kirino Y; Kamei C
J Allergy Clin Immunol; 2000 Nov; 106(5):896-903. PubMed ID: 11080712
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 activates human peripheral blood eosinophils.
Hoenstein R; Admon D; Solomon A; Norris A; Moqbel R; Levi-Schaffer F
Cell Immunol; 2001 Jun; 210(2):116-24. PubMed ID: 11520078
[TBL] [Abstract][Full Text] [Related]
14. The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.
Nials AT; Coleman RA; Johnson M; Vardey CJ
Br J Pharmacol; 1997 Mar; 120(5):961-7. PubMed ID: 9138705
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo.
Teixeira MM; Hellewell PG
Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847
[TBL] [Abstract][Full Text] [Related]
17. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
[TBL] [Abstract][Full Text] [Related]
18. Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.
McDonnell J; Latif ML; Rees ES; Bevan NJ; Hill SJ
Br J Pharmacol; 1998 Oct; 125(4):717-26. PubMed ID: 9831907
[TBL] [Abstract][Full Text] [Related]
19. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation.
Adamko DJ; Wu Y; Gleich GJ; Lacy P; Moqbel R
J Immunol Methods; 2004 Aug; 291(1-2):101-8. PubMed ID: 15345309
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.
White SR; Strek ME; Kulp GV; Spaethe SM; Burch RA; Neeley SP; Leff AR
J Clin Invest; 1993 May; 91(5):2118-25. PubMed ID: 8387540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
